Erica Kollmann GSK's Q3 Earnings Hit By Lower Than Expected Vaccine Sales, Cautions Lower Revenue For 2024 GSK reports Q3 sales of $10.42 billion, missing estimates due to an 18% drop in vaccine ...

FMCCH Federal Home Loan Mortgage Corporation 12.57 +5.84 (+86.78%) FMCKL Federal Home Loan Mortgage Corporation 6.82 +3.11 (+83.16%) FMCCM Federal Home Loan Mortgage Corporation 12.81 +5.81 (+83. ...

Jefferies analyst Peter Welford downgraded GSK (GSK) to Hold from Buy with a price target of $39.50, down from $53. The firm finds it “frustrating” that despite the favorable Zantac settlement, robust ...

FMCCH Federal Home Loan Mortgage Corporation 12.57 +5.84 (+86.78%) FMCKL Federal Home Loan Mortgage Corporation 6.82 +3.11 (+83.16%) FMCCM Federal Home Loan Mortgage Corporation 12.81 +5.81 (+83. ...

In a report released today, Peter Welford from Jefferies downgraded GlaxoSmithKline (GSK – Research Report) to a Hold, with a price ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

RSV vaccine sales from GSK and Pfizer have dropped significantly following revised CDC guidelines, narrowing the eligible age group and reducing demand by two-thirds compared to last year.

While generics may dominate due to cost advantages and meeting needs of a developing economy, there is a growing thrust ...